Heron Therapeutics (HRTX) PT Lowered to $32 at JMP Securities
Tweet
Share
E-mailGet Alerts HRTX Hot Sheet
Price: $0.36 --0%
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 15 | New: 50
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 15 | New: 50
Join SI Premium – FREE
JMP Securities analyst Liisa Bayko lowered the price target on Heron Therapeutics (NASDAQ: HRTX) to $32.00 (from $38.00) while maintaining a Market Outperform rating.
You May Also Be Interested In
- JPMorgan Upgrades Sandfire Resources NL (SFR:AU) (SNDFY) to Overweight
- Lotus Resources Ltd (LOT:AU) (LTSRF) PT Lowered to AUD0.24 at JPMorgan
- Chalice Mining Ltd (CHN:AU) PT Lowered to AUD1.25 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
